Jeffrey L. Ives

Insider Reports History

Entity
Individual
Location
C/O Cara Therapeutics, Inc., 1 Parrott Drive, Shelton, CT
Signature
/s/ Derek Meisner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey L. Ives:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cara Therapeutics, Inc. Director Common Stock 198K $149K $0.75 Jun 4, 2024 Direct
Cara Therapeutics, Inc. Director Stock Option (Right to Buy) 195K Jun 4, 2024 Direct
Acumen Pharmaceuticals, Inc. Director Stock Option (right to buy) 25K Jun 10, 2024 Direct
Acumen Pharmaceuticals, Inc. Director Common Stock 0 $3.47 Aug 17, 2023 Direct

Insider Reports Filed by Jeffrey L. Ives

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ABOS Acumen Pharmaceuticals, Inc. Jun 10, 2024 1 $0 4 Jun 10, 2024 Director
CARA Cara Therapeutics, Inc. Jun 4, 2024 2 $0 4 Jun 6, 2024 Director
ABOS Acumen Pharmaceuticals, Inc. Aug 17, 2023 6 -$241K 4 Aug 18, 2023 Director
ABOS Acumen Pharmaceuticals, Inc. Jun 6, 2023 1 $0 4 Jun 7, 2023 Director
CARA Cara Therapeutics, Inc. Jun 1, 2023 2 $0 4 Jun 5, 2023 Director
CARA Cara Therapeutics, Inc. Jul 15, 2022 1 -$32.6K 4 Jul 19, 2022 Director
ABOS Acumen Pharmaceuticals, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
CARA Cara Therapeutics, Inc. Jun 2, 2022 2 $0 4 Jun 6, 2022 Director
CARA Cara Therapeutics, Inc. Nov 12, 2021 1 -$131K 4 Nov 16, 2021 Director
ABOS Acumen Pharmaceuticals, Inc. Jun 30, 2021 1 $0 4 Jul 2, 2021 Director
ABOS Acumen Pharmaceuticals, Inc. Jun 30, 2021 0 $0 3 Jun 30, 2021 Director
CARA Cara Therapeutics, Inc. Jun 3, 2021 3 -$32.9K 4 Jun 7, 2021 Director